Stock News

OKYO Pharma Limited Announces Share Purchase by Executive Chairman London and New York, Aug. 23, 2024 OKYO Pharma Limited (NASDAQ: OKYO) – A Clinical-Stage Biopharmaceutical Company OKYO Pharma Limited, a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED) and anterior ocular segment diseases including neuropathic corneal pain…

Nuveen Real Asset Income and Growth Fund: A Closer Look Introduction The Nuveen Real Asset Income and Growth Fund is a closed-end fund that focuses on providing exposure to ‘real assets’ such as real estate and infrastructure. This unique investment opportunity offers investors a chance to diversify their portfolio and potentially earn a high yield…

Strengthens Qualcomm’s Industrial IoT Portfolio Expanding and Accelerating Digital Transformation Qualcomm Acquires Sequans’ 4G IoT Technologies Paris, France and San Diego, California–Qualcomm Incorporated, a global leader in high-performance low-power solutions, has made a strategic move to bolster its Industrial IoT portfolio by acquiring 4G IoT technologies from Sequans Communications S.A. This acquisition marks a significant…

Welcome to the So-Young International Inc. Financial Results Blog August 23, 2024 So-Young International Inc. Shines Bright in the Second Quarter Hey there, readers! Today we’re diving into the exciting world of So-Young International Inc., the largest social community in China for all things medical aesthetics. The company recently announced their unaudited financial results for…

Autoliv Declares Quarterly Dividend Stockholm, Aug. 23, 2024 /PRNewswire/ — Autoliv, Inc. (NYSE: ALV) and (SSE: ALIV.sdb) announced today that its Board of Directors has declared a quarterly dividend for the third quarter of 2024. Third Quarter Dividend Details The dividend declared is 68 cents per share. To be eligible for the dividend, shareholders must…

Welcome to Nexxen’s Second Quarter Earnings Call Overview Today, Nexxen International Ltd. (NASDAQ:NEXN) held its Q2 2024 Earnings Conference Call at 9:00 AM ET. The key speakers for this event included Billy Eckert, the Vice President of Investor Relations, Ofer Druker, the Chief Executive Officer, and Sagi Niri, the Chief Financial Officer. Various analysts and…

Aquestive Therapeutics Q2 Earnings Report Overview Significant Beats in EPS and Revenue The latest earnings report from Aquestive Therapeutics has shown impressive results, with a 52% year-over-year increase in revenue. The company exceeded expectations in both EPS and revenue, demonstrating strong growth and performance in the second quarter. Operational Efficiency and Profitability Aquestive reported improved…

Levi & Korsinsky Investigates Cardlytics, Inc. for Securities Law Violations Recently, Levi & Korsinsky announced that they have initiated an investigation into Cardlytics, Inc. This investigation is centered around potential violations of federal securities laws. Cardlytics, a company listed on the NASDAQ under the ticker symbol CDLX, disclosed their second quarter financial results on August…